Deep insight on mechanism and contribution of arsenic removal and heavy metals remediation by mechanical activation phosphogypsum.

Arsenic-containing wastewater and arsenic-contaminated soil can cause serious environmental pollution. In this study, phosphogypsum with partial mechanical activation of calcium oxide was used to prepare a new phosphogypsum-based passivate (Ca-mPG), and its remediation performance on arsenic-contaminated soil was evaluated in terms of both effectiveness and microbial response. The results showed that the optimum conditions for the preparation of the passivate were optimized in terms of single factor and response surface with a ball milling speed of 200 r/min, a material ratio of 6:4 and a ball milling time of 4 h. Under these conditions, the adsorption capacity was 37.75 mg/g. The leaching concentration of arsenic (As) in the contaminated soil after Ca-mPG modification decreased from 25.75 µg/L to 5.88 µg/L, which was lower than the Chinese national standard (GB/T 5085.3-2007); Ca-mPG also showed excellent passivation effect on other heavy Metals (copper, nickel, cadmium, zinc). In addition, As-resistant bacteria and passivators work together to promote the stabilization effect of contaminants during the remediation of As-contaminated soil. The mechanisms of Cu, As(III)/As(V), Zn, Cd, and Ni removal were related to ion exchange, electrostatic adsorption of substances on heavy metals, calcium binding to other substances to produce precipitation; and microbially induced stabilization of HMs, oxidized. Overall, this study demonstrates an eco-friendly "waste-soil remediation" strategy to solve problems associated with solid waste reuse and remediation of HM-contaminated soils.

Simultaneous immobilization of multiple heavy metals in polluted soils amended with mechanical activation waste slag.

Heavy metal soil contamination has become an increasingly serious problem in industrial development. However, industrial byproducts used for remediation are one aspect of green remediation that can contribute to sustainable practices in waste recycling. In this study, electrolytic manganese slags (EMS) were mechanically activated and modified into a passivator (M-EMS), and the heavy metal adsorption performance of M-EMS, heavy metal passivation ability in soil, dissolved organic matter (DOM) change and its effect on the microbial community structure of soil were investigated. The findings revealed that the maximum adsorption capacities of As(V), Cd2+, Cu2+ and Pb2+ were 76.32 mg/g, 301.41 mg/g, 306.83 mg/g and 826.81 mg/g, respectively, indicating that M-EMS demonstrated remarkable removal performance for different heavy metals. The Langmuir model fits Cd2+, Cu2+ and Pb2+ better than the Freundlich model, and monolayer adsorption is the main process. Surface complexation played a major role in the As(V) adsorption's on the surface of metal oxides in M-EMS. The passivation effect was ranked as Pb > Cr > As>Ni > Cd > Cu, with the highest passivation rate of 97.59 % for Pb, followed by Cr (94.76 %), then As (71.99 %), Ni (65.17 %), Cd (61.44 %), and the worst one was Cu (25.17 %). In conclusion, the passivator has the effect of passivation for each heavy metal. The addition of passivating agent can enhance the diversity of microorganisms. Then it can change the dominant flora and induce the passivation of heavy metals through microorganisms. XRD, FTIR, XPS and the microbial community structure of soil indicated that M-EMS can stabilize heavy metals in contaminated soils through four main mechanisms: ion exchange, electrostatic adsorption, complex precipitation and the microbially induced stabilization. The results of this study may provide new insights into the ecological remediation of multiple heavy-metal-contaminated soils and water bodies and research on the strategy of waste reduction and harmlessness by using EMS-based composites in combination with heavy metals in soil.

Preparation of phosphogypsum-copper smelting slag-based consolidating body with high compressive strength.

Phosphogypsum (PG) is an industrial waste residue produced during the production of phosphoric acid through the wet process. With strong acidity and a large amount of toxic impurities, PG is difficult to reuse. In this study, the solidified body (PG-S) was made by mechanical compression of the mixture of PG, copper smelting slag (CSS), CaO, NaOH, and water. Results indicate that the composition of the material phases in the PG-S samples changed with hydrated calcium silicate and amorphous silicate derivatives were formed during the reaction; Fe and Ca in the material were transformed; and the prepared geopolymer material had a dense internal structure with the materials being cemented to each other. The highest compressive strength of PG-S cured for 28 days could reach 21.3 MPa with a fixation efficiency of PO43-and F-reaching 99.81 and 94.10%, respectively. The leaching concentration of heavy metals of the PG-S cured for 28 days met the requirements of the Comprehensive Wastewater Discharge Standard (GB 8978-1996). The simulation results of the geochemical model verified the feasibility of the whole immobilization process from the thermodynamic point of view. This work directly uses copper smelting slag and phosphogypsum for coupled immobilization/stabilization treatment not only to achieve the immobilization of pollutants in both solid wastes but also to obtain colloidal masses with certain compressive strength, which also provides a new option for resource utilization of phosphogypsum and copper smelting slag. This work also shows great potential in turning the actual mine backfill into cementitious material.

Pulmonary sarcoidosis: A novel sequelae of drug reaction with eosinophilia and systemic symptoms: A case report.

BACKGROUND: Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is an uncommon yet serious adverse drug hypersensitivity reaction with the presentations including rash, fever, lymphadenopathy, and internal organ involvement. Sarcoidosis is a systematic granulomatous disease with unknown etiology. We herein report a case of pulmonary sarcoidosis secondary to allopurinol-induced DRESS. CASE SUMMARY: A 37-year-old man with a history of hyperuricemia was treated with allopurinol for three weeks at a total dose of 7000 milligrams before developing symptoms including anorexia, fever, erythematous rash, and elevated transaminase. The patient was diagnosed with DRESS and was treated with prednisone for 6 mo until all the symptoms completely resolved. Three months later, the patient presented again because of a progressively worsening dry cough. His chest computed tomography images showed bilateral lung parenchyma involvement with lymph node enlargement, which was confirmed to be nonnecrotizing granuloma by pathological examination. Based on radiologic and pathological findings, he was diagnosed with sarcoidosis and was restarted on treatment with prednisone, which was continued for another 6 mo. Reexamination of chest imaging revealed complete resolution of parenchymal lung lesions and a significant reduction in the size of the mediastinal and hilar lymph nodes. Following a 6-month follow-up of completion of treatment, the patient's clinical condition remained stable with no clinical evidence of relapse. CONCLUSION: This is the first case in which pulmonary sarcoidosis developed as a late complication of allopurinol-induced DRESS. The case indicated that the autoimmune reaction of DRESS may play an important role in the pathogenesis of sarcoidosis.

Risk of intracranial hemorrhage with direct oral anticoagulants: a systematic review and meta-analysis of randomized controlled trials.

OBJECTIVE: We performed a systematic review and meta-analysis to compare the risk of intracranial hemorrhage (ICH) between direct oral anticoagulants (DOACs) and other antithrombotic drugs in detail across all diseases. METHODS: PubMed, EMBASE, Web of Science, and the Cochrane Library were searched for relevant randomized controlled trials (RCTs). Heterogeneity was examined using the I2 statistic. Risk ratio (RR) and 95% confidence interval (CI) were calculated using random-effects meta-analysis. RESULTS: Fifty-five RCTs were included in this meta-analysis. Compared with vitamin K antagonists (VKAs), dabigatran reduced the risk of ICH by 60% (RR 0.40; 95% CI 0.28-0.57), apixaban by 57% (RR 0.43; 95% CI 0.31-0.58), edoxaban by 56% (RR 0.44; 95% CI 0.29-0.67) and rivaroxaban by 41% (RR 0.59; 95%CI 0.44-0.80). Compared with low-molecular-weight heparins (LMWHs), apixaban, edoxaban and rivaroxaban had a similar risk of ICH. Compared with aspirin, dabigatran and apixaban had a similar risk of ICH, while rivaroxaban posed an increased risk of ICH (RR 2.12; 95% CI 1.31-3.44). For secondary prevention stroke, DOACs reduced the risk of ICH by 46% compared with warfarin (RR 0.54; 95% CI [0.42-0.70]) and had a similar risk of ICH compared with aspirin. CONCLUSION: All DOACs had a lower risk of ICH than VKAs. In terms of the risk of ICH, DOACs were overall as safe as LMWHs, and apixaban and dabigatran were as safe as aspirin, but rivaroxaban was not. For secondary prevention stroke, the risk of ICH with DOACs was overall lower than warfarin and similar to aspirin, but it should be noted that compared with aspirin, rivaroxaban may increase the risk of ICH. This is the first pair-wise meta-analysis that compares the risk of ICH between DOACs and other antithrombotic drugs in detail across all diseases, which may have certain significance for patients with high risk of ICH to choose antithrombotic drugs in clinical practice.

GEPSI: A Gene Expression Profile Similarity-Based Identification Method of Bioactive Components in Traditional Chinese Medicine Formula.

The identification of bioactive components in traditional Chinese medicine (TCM) is an important part of the TCM material foundation research. Recently, molecular docking technology has been extensively used for the identification of TCM bioactive components. However, target proteins that are used in molecular docking may not be the actual TCM target. For this reason, the bioactive components would likely be omitted or incorrect. To address this problem, this study proposed the GEPSI method that identified the target proteins of TCM based on the similarity of gene expression profiles. The similarity of the gene expression profiles affected by TCM and small molecular drugs was calculated. The pharmacological action of TCM may be similar to that of small molecule drugs that have a high similarity score. Indeed, the target proteins of the small molecule drugs could be considered TCM targets. Thus, we identified the bioactive components of a TCM by molecular docking and verified the reliability of this method by a literature investigation. Using the target proteins that TCM actually affected as targets, the identification of the bioactive components was more accurate. This study provides a fast and effective method for the identification of TCM bioactive components.